{"symbol":"PFE","fiscalQuarter":"Q1-2011","reportDate":"2011-05-03","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q1-2011","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 2.76%","keyNumbers":[{"metric":"EPS","actual":"$0.60","expected":"N/A","surprise":"+3.81%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed satisfaction with the EPS results despite not providing revenue figures.","They emphasized ongoing efforts to innovate and expand their product pipeline."],"summary":"Overall, management conveyed a sense of cautious optimism about the company's performance. They highlighted their focus on future growth despite the lack of revenue guidance."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Pfizer's earnings report shows that they exceeded expectations on EPS, which is a positive sign for the company. However, the stock fell by 2.76%, likely due to the absence of revenue figures and guidance, leaving investors uncertain about future performance. The market reaction suggests that investors were looking for more comprehensive data to assess the company's outlook.","metaDescription":"Pfizer Inc (PFE) Q1 2011 earnings: EPS beat by 3.81%. Stock down 2.76%. Full breakdown."}}